Status:
UNKNOWN
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
Lead Sponsor:
Sir Run Run Shaw Hospital
Conditions:
Klebsiella Pneumoniae Infection
Eligibility:
All Genders
18-85 years
Brief Summary
Klebsiella pneumoniae is one of the most common pathogens causing nosocomial infection. Recently, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be v...
Detailed Description
All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as b...
Eligibility Criteria
Inclusion
- new confirmed noscomial infection of CRKP
Exclusion
- Age\<18, or \>85 years old; Mixed infection of CRKP and other microbes
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT03245632
Start Date
August 1 2017
End Date
December 1 2019
Last Update
August 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China, 310016